Treatment.Com International Inc. (TRUE.CN)
CAD 0.44
(3.57%)
CAD 0.44
(3.57%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 739.3 Thousand CAD | 5306.65% |
| 2022 | 13.67 Thousand CAD | -98.55% |
| 2021 | 942.51 Thousand CAD | 200.93% |
| 2020 | 313.2 Thousand CAD | -39.23% |
| 2019 | 515.39 Thousand CAD | 711.41% |
| 2018 | 63.51 Thousand CAD | 476.34% |
| 2017 | 11.02 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.03 Million CAD | -62.15% |
| 2024 Q1 | 2.72 Million CAD | 268.31% |
| 2023 Q4 | 739.3 Thousand CAD | -28.9% |
| 2023 Q3 | 1.03 Million CAD | 22156.98% |
| 2023 Q2 | 4672.00 CAD | -74.34% |
| 2023 Q1 | 18.2 Thousand CAD | 33.17% |
| 2023 FY | 739.3 Thousand CAD | 5306.65% |
| 2022 Q4 | 13.67 Thousand CAD | -74.88% |
| 2022 Q2 | 21.45 Thousand CAD | -91.92% |
| 2022 Q1 | 265.44 Thousand CAD | -71.84% |
| 2022 FY | 13.67 Thousand CAD | -98.55% |
| 2022 Q3 | 54.43 Thousand CAD | 153.7% |
| 2021 Q1 | 1.54 Million CAD | 393.02% |
| 2021 FY | 942.51 Thousand CAD | 200.93% |
| 2021 Q4 | 942.51 Thousand CAD | -60.68% |
| 2021 Q3 | 2.39 Million CAD | -50.78% |
| 2021 Q2 | 4.86 Million CAD | 215.36% |
| 2020 Q4 | 313.2 Thousand CAD | -67.58% |
| 2020 Q1 | - CAD | -100.0% |
| 2020 Q3 | 966.21 Thousand CAD | 0.0% |
| 2020 FY | 313.2 Thousand CAD | -39.23% |
| 2019 FY | 515.39 Thousand CAD | 711.41% |
| 2019 Q4 | 515.39 Thousand CAD | 0.0% |
| 2018 FY | 63.51 Thousand CAD | 476.34% |
| 2017 FY | 11.02 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AI/ML Innovations Inc. | 329.68 Thousand CAD | -124.244% |
| Diagnamed Holdings Corp. | 662.27 Thousand CAD | -11.632% |
| Pangenomic Health Inc. | 71.47 Thousand CAD | -934.313% |
| nDatalyze Corp. | 877.9 Thousand CAD | 15.788% |
| Unidoc Health Corp. | 517.08 Thousand CAD | -42.976% |